You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 8, 2024

APADAZ Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Apadaz patents expire, and what generic alternatives are available?

Apadaz is a drug marketed by Zevra Therap and is included in one NDA. There are five patents protecting this drug.

This drug has thirty-five patent family members in twenty countries.

The generic ingredient in APADAZ is acetaminophen; benzhydrocodone hydrochloride. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; benzhydrocodone hydrochloride profile page.

DrugPatentWatch® Generic Entry Outlook for Apadaz

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be February 22, 2031. This may change due to patent challenges or generic licensing.

Indicators of Generic Entry

< Available with Subscription >

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for APADAZ?
  • What are the global sales for APADAZ?
  • What is Average Wholesale Price for APADAZ?
Summary for APADAZ
International Patents:35
US Patents:5
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 1
Drug Prices: Drug price information for APADAZ
What excipients (inactive ingredients) are in APADAZ?APADAZ excipients list
DailyMed Link:APADAZ at DailyMed
Drug patent expirations by year for APADAZ
Drug Prices for APADAZ

See drug prices for APADAZ

DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for APADAZ
Generic Entry Date for APADAZ*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

US Patents and Regulatory Information for APADAZ

APADAZ is protected by six US patents.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of APADAZ is ⤷  Sign Up.

This potential generic entry date is based on patent ⤷  Sign Up.

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting APADAZ

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: MANAGEMENT OF ACUTE PAIN SEVERE ENOUGH TO REQUIRE AN OPIOID ANALGESIC AND FOR WHICH ALTERNATIVE TREATMENTS ARE INADEQUATE

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zevra Therap APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-002 Jan 4, 2019 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Zevra Therap APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-001 Feb 23, 2018 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Zevra Therap APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-002 Jan 4, 2019 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Zevra Therap APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-003 Jan 4, 2019 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for APADAZ

When does loss-of-exclusivity occur for APADAZ?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Australia

Patent: 10266205
Patent: Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
Estimated Expiration: ⤷  Sign Up

Brazil

Patent: 2012000569
Patent: ácido benzóico, derivados de ácido benzóico e conjugados de ácido heteroaril carboxílico de hidrocodona, pró-farmacos, métodos de produção e uso destes
Estimated Expiration: ⤷  Sign Up

Canada

Patent: 66388
Patent: ACIDE BENZOIQUE, DERIVES D'ACIDE BENZOIQUE ET CONJUGUES D'ACIDEHETEROARYLCARBOXYLIQUEE D'HYDROCODONE, PROMEDICAMENTS, LEURS PROCEDES DE FABRICATION ET D'UTILISATION (BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF)
Estimated Expiration: ⤷  Sign Up

Chile

Patent: 11003347
Patent: Composicion farmaceutica que comprende un conjugado, correspondiente a benzoato de hidrocodona ; y uso en el tratamiento de una enfermedad, trastorno o afeccion mediada por la union de un opioide a receptores opioides.
Estimated Expiration: ⤷  Sign Up

China

Patent: 2480959
Patent: Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
Estimated Expiration: ⤷  Sign Up

Colombia

Patent: 80991
Patent: ACIDO BENZOICO, DERIVADOS DE ACIDO BENZOICO Y CONJUGADOS DE ACIDO HETEROARIL CARBOXILICO DE HIDROCODONA, PROFARMACOS, METODOS PARA ELABORAR Y UTILIZAR LOS MISMOS
Estimated Expiration: ⤷  Sign Up

Costa Rica

Patent: 110688
Patent: CONJUGADOS DE HIDROCODONA CON ÁCIDO BENZOICO, DERIVADOS DE ÁCIDO BENZOICO Y ÁCIDO CARBOXÍLICO HETEROARÍLICO, PROFÁRCOS, MÉTODOS DE PREPARACIÓN Y USO DE LOS MISMOS
Estimated Expiration: ⤷  Sign Up

Cuba

Patent: 128
Patent: COMPUESTO DE BENZOATO CONJUGADO A LA HIDROCODONA (BZ-HC)
Estimated Expiration: ⤷  Sign Up

Patent: 110246
Patent: ÁCIDO BENZOICO, DERIVADOS DE ÁCIDO BENZOICO Y CONJUGADOS DE ÁCIDO HETEROARIL CARBOXÍLICO DE HIDROCODONA, PROFÁRMACOS, MÉTODOS PARA ELABORAR Y UTILIZAR LOS MISMOS
Estimated Expiration: ⤷  Sign Up

European Patent Office

Patent: 48407
Patent: ACIDE BENZOÏQUE, DÉRIVÉS D'ACIDE BENZOÏQUE ET CONJUGUÉS D'ACIDEHÉTÉROARYLCARBOXYLIQUEE D'HYDROCODONE, PROMÉDICAMENTS, LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION (BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF)
Estimated Expiration: ⤷  Sign Up

Patent: 60336
Patent: ACIDE BENZOÏQUE, DÉRIVÉS D'ACIDE BENZOÏQUE ET CONJUGUÉS D'ACIDE CARBOXYLIQUE HÉTÉROARYLE D'HYDROCODONE, PROMÉDICAMENTS, PROCÉDÉS DE FABRICATION ET D'UTILISATION (BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF)
Estimated Expiration: ⤷  Sign Up

Israel

Patent: 7096
Patent: תכשירים הכוללים תצמידים של בנזואט הידרוקודון ושימושים בהם (Compositions comprising conjugates of benzoate hydrocodone and use thereof)
Estimated Expiration: ⤷  Sign Up

Patent: 9889
Patent: תצמידי חומצה בנזואית, תולדות חומצה בנזואית וחומצה קרבוקסילית הטרוארילית של הידרוקודון, מטרימי תרופות, שיטות להכנתם ושימוש בהם (Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof)
Estimated Expiration: ⤷  Sign Up

Japan

Patent: 42862
Estimated Expiration: ⤷  Sign Up

Patent: 12532142
Estimated Expiration: ⤷  Sign Up

Malaysia

Patent: 3046
Patent: BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF
Estimated Expiration: ⤷  Sign Up

Mexico

Patent: 12000128
Patent: ACIDO BENZOICO, DERIVADOS DE ACIDO BENZOICO Y CONJUGADOS DE ACIDO HETEROARIL CARBOXILICO DE HIDROCODONA, PROFARMACOS METODOS PARA ELABORALOS Y SUS USOS. (BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF.)
Estimated Expiration: ⤷  Sign Up

New Zealand

Patent: 7235
Patent: BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF
Estimated Expiration: ⤷  Sign Up

Russian Federation

Patent: 05541
Patent: КОНЪЮГАТЫ ГИДРОКОДОНА С БЕНЗОЙНОЙ КИСЛОТОЙ, ПРОИЗВОДНЫМИ БЕНЗОЙНОЙ КИСЛОТЫ И ГЕТЕРОАРИЛКАРБОНОВОЙ КИСЛОТОЙ, ПРОЛЕКАРСТВА, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ (CONJUGATES OF HYDROCODONE WITH BENZOIC ACID, DERIVATIVES OF BENZOIC ACID AND HETERO-ACRYL-CARBON ACID, PRODRUGS, METHODS FOR THEIR OBTAINING AND APPLICATION)
Estimated Expiration: ⤷  Sign Up

Patent: 12103476
Patent: КОНЪЮГАТЫ ГИДРОКОДОНА С БЕНЗОЙНОЙ КИСЛОТОЙ, ПРОИЗВОДНЫМИ БЕНЗОЙНОЙ КИСЛОТЫ И ГЕТЕРОАРИЛКАРБОНОВОЙ КИСЛОТОЙ, ПРОЛЕКАРСТВА, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ
Estimated Expiration: ⤷  Sign Up

Singapore

Patent: 7445
Patent: BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF
Estimated Expiration: ⤷  Sign Up

South Africa

Patent: 1109438
Patent: BENZOIC ACID,BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE,PRODRUGS,METHODS OF MAKING AND USE THEREOF
Estimated Expiration: ⤷  Sign Up

Patent: 1300747
Patent: BENZOIC ACID,BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE,PRODRUGS,METHODS OF MAKING AND USE THEREOF
Estimated Expiration: ⤷  Sign Up

South Korea

Patent: 1655972
Estimated Expiration: ⤷  Sign Up

Patent: 1795330
Estimated Expiration: ⤷  Sign Up

Patent: 1877467
Estimated Expiration: ⤷  Sign Up

Patent: 1971223
Estimated Expiration: ⤷  Sign Up

Patent: 2038260
Estimated Expiration: ⤷  Sign Up

Patent: 120048589
Patent: BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF
Estimated Expiration: ⤷  Sign Up

Patent: 160106781
Patent: 히드로코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트, 이의 전구약물, 제조 방법 및 용도 (BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF)
Estimated Expiration: ⤷  Sign Up

Patent: 170124638
Patent: 히드로코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트, 이의 전구약물, 제조 방법 및 용도 (BENZOIC ACID BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE PRODRUGS METHODS OF MAKING AND USE THEREOF)
Estimated Expiration: ⤷  Sign Up

Patent: 180081176
Patent: 히드로코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트, 이의 전구약물, 제조 방법 및 용도 (BENZOIC ACID BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE PRODRUGS METHODS OF MAKING AND USE THEREOF)
Estimated Expiration: ⤷  Sign Up

Patent: 190042115
Patent: 히드로코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트, 이의 전구약물, 제조 방법 및 용도 (BENZOIC ACID BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE PRODRUGS METHODS OF MAKING AND USE THEREOF)
Estimated Expiration: ⤷  Sign Up

Ukraine

Patent: 2916
Patent: КОМПОЗИЦИЯ НА ОСНОВЕ КОНЬЮГАТА ГИДРОКОДОНА С БЕНЗОЛЬНОЙ КИСЛОТОЙ, ПРОИЗВОДНЫМИ БЕНЗОЙНОЙ КИСЛОТ ИЛИ ГЕТЕРОАРИЛКАРБОНОВОЙ КИСЛОТОЙ, ПРОЛЕКАРСТВА, СПОСОБ ЛЕЧЕНИЯ ОТ ЗЛОУПОТРЕБЛЕНИЙ;КОМПОЗИЦІЯ НА ОСНОВІ КОН'ЮГАТУ ГІДРОКОДОНУ З БЕНЗОЙНОЮ КИСЛОТОЮ, ПОХІДНИМИ БЕНЗОЙНОЇ КИСЛОТИ АБО ГЕТЕРОАРИЛКАРБОНОВОЮ КИСЛОТОЮ, ПРОЛІКИ, СПОСІБ ЛІКУВАННЯ ВІД ЗЛОВЖИВАНЬ (COMPOSITION BASED ON CONJUGATES OF HYDROCODONE WITH BENZOIC ACID, BENZOIC ACID OR HETEROARYL CARBOXYLIC ACID DERIVATIVES, PRODRUGS AND METHOD FOR TREATMENT OF ABUSES)
Estimated Expiration: ⤷  Sign Up

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering APADAZ around the world.

Country Patent Number Title Estimated Expiration
South Korea 20190042115 히드로코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트, 이의 전구약물, 제조 방법 및 용도 (BENZOIC ACID BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE PRODRUGS METHODS OF MAKING AND USE THEREOF) ⤷  Sign Up
Russian Federation 2012103476 КОНЪЮГАТЫ ГИДРОКОДОНА С БЕНЗОЙНОЙ КИСЛОТОЙ, ПРОИЗВОДНЫМИ БЕНЗОЙНОЙ КИСЛОТЫ И ГЕТЕРОАРИЛКАРБОНОВОЙ КИСЛОТОЙ, ПРОЛЕКАРСТВА, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2011002991 ⤷  Sign Up
Mexico 2012000128 ACIDO BENZOICO, DERIVADOS DE ACIDO BENZOICO Y CONJUGADOS DE ACIDO HETEROARIL CARBOXILICO DE HIDROCODONA, PROFARMACOS METODOS PARA ELABORALOS Y SUS USOS. (BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF.) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.